The primary treatment options for kidney cancer include surgery, radiofrequency ablation, radiation therapy, chemotherapy, targeted therapies and immunotherapy. Tumours that are small and confined to the kidney may only require active surveillance to monitor the cancer through regular tests and scans. The type of treatment you receive will depend on a number of different considerations, such as the type of kidney cancer you have, its stage, your overall health and your treatment preferences. This page aims to give you a comprehensive overview of how kidney cancer treatment works in the private health system.
Surgery for kidney cancerSurgery
Surgery is often the first step in treating kidney cancer. In most cases, part or all of the kidney is removed. If the cancer has spread beyond the kidney, other cancerous tissue, including surrounding lymph nodes, may also be removed. Surgical options for the treatment of kidney cancer include:
A radical nephrectomy involves surgically removing the entire kidney, as well as a section of the surrounding healthy tissue. In some cases, nearby lymph nodes and adrenal glands may also be removed. A nephrectomy may be performed through a single incision to the abdomen or through laparoscopic surgery, where several small incisions are made to access the kidney through the abdomen.
A partial nephrectomy, also referred to as kidney-sparing or nephron-sparing surgery, is a procedure which removes the cancerous tumour from within the kidney along with a small amount of surrounding healthy tissue. Unlike a radical nephrectomy, only part of the kidney will be removed. This type of surgery is the preferred course of treatment, as it may save kidney function.
Radiofrequency ablation for kidney cancerRadiofrequency ablation
Radiofrequency ablation is a less common treatment option for kidney cancer and is typically used for patients who are considered unfit to undergo surgery. This method destroys cancer cells through inserting a needle directly into the tumour, which then directs electrical currents into the cancerous tissue.
Radiation therapy for kidney cancer Radiation therapy
Types of radiation therapy commonly used for people with kidney cancer include:
Most patients who receive radiation therapy for kidney cancer will receive external beam radiation therapy. The most common type of EBRT treatment for kidney cancer is stereotactic radiation therapy (SBRT/SABR), which is used to treat small tumours in the kidney with well-defined edges when surgery is not recommended.
Chemotherapy for kidney cancerChemotherapy
Chemotherapy uses a range of drugs to kill and slow the growth of kidney cancer cells. Typically, chemotherapy is only used to treat advanced kidney cancer that does not respond to other treatments, including targeted therapies and immunotherapy. In certain circumstances, chemotherapy drugs may be used in combination with targeted therapy and immunotherapy to help shrink kidney cancer cells.
Common chemotherapy medicines
There are a number of different chemotherapy drugs that are used to treat kidney cancer. These drugs are typically combined based on the type of kidney cancer you have, your cancer’s stage and how much it has spread. Some of the drugs used include:
This works by stopping the production of thiamine within cancer cells so they are not able to make the essentials proteins (RNA and DNA) that they need to divide and grow. It is given by intravenous infusion, usually in combination with a targeted therapy drug.
Targeted therapy for kidney cancerTargeted therapy
Targeted therapies use specialised drugs to destroy specific proteins in kidney cancer cells. They are commonly used to treat advanced kidney cancer and kidney cancer that is growing quickly.
Tyrosine kinase inhibitors (TKIs)
These drugs work by blocking a protein called VEGF (vascular endothelial growth factor growth) on the surface of kidney cancer cells. By blocking the VEGF protein, kidney cancer cells no longer get the nutrients they need to grow and spread. These medications are usually taken orally as a tablet or capsule once or twice daily.
TKI drugs include:
These work by blocking a protein called mTOR which stimulates kidney cancer cells to grow. Blocking this protein helps to slow down the growth of kidney cancer cells.
Common mTOR inhibitor medicines
mTOR inhibitor drugs for kidney cancer include:
This is given by intravenous infusion every week, with each infusion usually taking around one hour. It is used to treat advanced (metastatic) kidney cancer.
This is given orally as a capsule once daily. It is usually given as a second line treatment, following treatment with a tyrosine kinase inhibitor drug.
Immunotherapy for kidney cancerImmunotherapy
Immunotherapy treatment uses your own immune system to destroy and slow the growth of kidney cancer cells. Like other drug-based therapies, immunotherapy is usually only recommended for the treatment of advanced kidney cancers and to help prevent kidney cancer from returning.
Immunotherapy drugs can be combined with targeted therapy drugs to treat advanced (or metastatic) kidney cancer.
Monoclonal antibody drugs
Most immunotherapy drugs that are used to treat kidney cancer are knowns as monoclonal antibody drugs, which belong to a class of drugs called checkpoint inhibitors. They work by binding onto certain ‘checkpoints’ (PD-1, PD-L1 and CTL-4) on the surface of T cells, which allows them to detect and destroy cancer cells or slow their growth.
Common monoclonal antibody medicines
Some common monoclonal antibody drugs which are used to treat kidney cancer include:
This is given by intravenous infusion every three weeks, with each infusion taking around one hour. It may be given alone or in combination with ipilimumab.
This is given by intravenous infusion every two weeks to three weeks and is usually given together with nivolumab.
This is typically given by intravenous infusion every two weeks. It may be given in combination with a targeted therapy drug called axitinib.
Icon offers a wide range of clinical trials providing patients with access to new and evolving treatments. Clinical trials offer hope and opportunity and contribute to breakthroughs in treatment for future cancer patients.
When you are diagnosed with kidney cancer, your oncologist will develop your treatment plan as part of a multidisciplinary team based on the stage of your cancer.
Common treatment options for each stage of kidney cancer include:
Stage I and II kidney cancer
For early-stage kidney cancers, active surveillance may be an option if tumours are small and confined to the kidney. If further treatment is required, a partial or radical nephrectomy is usually performed while the cancer is still contained to the kidney. A lymphadenectomy may also be performed to remove surrounding lymph nodes.
Stage III kidney cancer
Stage III kidney cancers are treated similarly to stage I and II kidney cancer. Treatment will usually begin with a radical nephrectomy and lymphadenectomy. Following surgery, you may receive targeted therapies and immunotherapy to lower the risk of your cancer returning.
Stage IV kidney cancer
Treatment for stage IV kidney cancer typically begins with surgery. However, advanced kidney cancer is considered very difficult to cure and, in many cases, treatment will focus on palliative care to manage your pain. After surgery, you may receive immunotherapy, targeted therapy or chemotherapy to treat your cancer and manage your symptoms. Radiation therapy may also be used to treat areas in which the cancer has spread.
- The American Society of Clinical Oncology. (2021, November 19). Kidney cancer – types of treatment. Cancer.Net. Retrieved December 20, 2021, from www.cancer.net/cancer-types/kidney-cancer/types-treatment
- Mayo Foundation for Medical Education and Research. (2020, June 25). Kidney cancer: diagnosis & treatment. Mayo Clinic. Retrieved December 20, 2021, from www.mayoclinic.org/diseases-conditions/kidney-cancer/diagnosis-treatment/drc-20352669
- Cancer Council Victoria. Kidney cancer: Treatment for early kidney cancer. Cancer Council Victoria. (n.d.). Retrieved December 20, 2021, from www.cancervic.org.au/cancer-information/types-of-cancer/kidney_cancer/treatment_for_kidney_cancer.html
- American Cancer Society. (2021, November 2). Chemotherapy for kidney cancer. American Cancer Society. Retrieved December 20, 2021, from www.cancer.org/cancer/kidney-cancer/treating/chemotherapy.html
- Cancer Council. (2020, November). Kidney cancer: Causes, symptoms & treatments. Cancer Council. Retrieved December 20, 2021, from http://www.cancer.org.au/cancer-information/types-of-cancer/kidney-cancer www.cancer.org/cancer/kidney-cancer/treating/by-stage.html
- B. Escudier, C. Porta, M. Schmidinge, S. Gillessen, A. Horwich. Annals of Oncology Special articles| Volume 30, ISSUE 5, P706-720, May 01, 2019. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. DOI:https://doi.org/10.1093/annonc/mdz056
Helpful linksBecoming a patient
What you need to know about cancer research and clinical trials
View a Facebook Live with Icon specialists from across Singapore and Australia
Clinical Opinion Articles
Five tips for life beyond cancer treatment
Icon Medical Director and Clinical Haematologist Dr Ian Irving shares his advice on how to stay well and find your new normal once treatment ends
Become a patient
Find out how to become a patient at Icon Cancer Centre, or request more information from your nearest centre.
Icon brings together some of Australia’s most experienced medical oncologists, radiation oncologists and haematologists.
Care at Icon
At Icon, care is more than just a word. Our cancer care team are here to support you with compassion, knowledge and hope.
Our patients share their perspective and advice.